NEW YORK, N.Y., March 12, 2024 (Korea Bizwire) – The Women in the Digital Economy Fund (WiDEF), a five-year $60.5 million investment to accelerate progress on closing the global gender digital divide, announces its first call for applications with recorded remarks from the United States Agency for International Development (USAID) Administrator Samantha Power. Founded by USAID and the [...]
March 12, 2024 Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of clinical workflow leadership with scalable cloud solution to help accelerate decision-making and further transform patient care Amsterdam, the Netherlands and Orlando, USA (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in [...]
Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C., March 11, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization [...]
Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood LONDON, March 11, 2024 (Korea Bizwire) – Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, [...]
Solidifying Its Position as a Leading Medical Tourism Hub KUALA LUMPUR, Malaysia, March 07, 2024 (Korea Bizwire) – In a monumental achievement for the nation, two Malaysian hospitals have been recognised in the highly respected Newsweek & Statista’s World’s Best Hospitals 2024. This marks Malaysia’s first-ever inclusion, signifying a pivotal moment in its journey towards [...]
WALTHAM, Mass., March 06, 2024 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of the Audit Committee. Ms. Allen [...]
March 6, 2024 (Korea Bizwire) – Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included in the 2024 Clarivate Top 100 Global Innovator™ list. Philips’ global R&D programs and collaborations aim to deliver personal [...]
Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®* (denosumab) FDA approval based on robust clinical studies and totality of evidence, which show no clinically meaningful differences from reference medicines Basel, March 5, 2024 (Korea Bizwire) – Sandoz, the global leader in generic and biosimilar medicines, [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Mathai Mammen and Michael Rechsteiner nominated to stand for election to Sandoz Board of Directors at upcoming Annual General Meeting Remco Steenbergen appointed as Sandoz CFO and member of Executive Committee as of July 1, 2024, and consequently not standing for [...]
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. Vancouver, Canada & London, United Kingdom, March 05, 2024 (Korea Bizwire) — Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based pharmaceutical industry, is proud to announce [...]